The exact prevalenceÂ of HIV-associated lipodystrophy has been challenging to establish due to differences in case definition, but estimates range from 10% to 80% among all people living with HIV worldwide.

A 2005 study evaluating 452 patients reported a baseline prevalence of 35% for fat atrophy, 44% for fat accumulation (central adiposity), and 14% for a combination of the two syndromes in patients living with HIV.